• ADECATUMUMAB chembl:CHEMBL2108018 Antineoplastic

    Alternate Names:

    MT-201
    ADECATUMUMAB

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 15.46

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name adecatumumab, MT201
    Novel drug target Novel Target
    Mechanism of Interaction Epithelial cell adhesion molecule inhibitor

    PMIDs:
    None found